Managing Treatment Challenges in HER2-Directed Therapies

Key Takeaways

• Understanding molecular mechanisms of resistance is crucial for developing novel therapeutic agents and combination strategies in HER2-directed therapies.
• Personalized medicine, utilizing genomic profiling, is expected to tailor treatments to individual patient profiles, enhancing efficacy.
• Integrating immunotherapy with targeted therapies may provide synergistic effects, improving treatment outcomes.
• Continuous clinical trials and translational research are essential to refine strategies and improve patient outcomes in HER2-directed therapies.